Tharlow,
You are totally inconsistent. In a ChemGenex (CXS) post, you spruik Ceflatonin as a drug with massive potential and above refer to PI-88 as a "specialty drug".
Man! I think you've got the two mixed up! Ceflatonin is targetted at a small portion of the already relatively small (and crowded) Chronic Myeloid Leukaemia market!! Whereas, PI-88 could be applicable to a broad range of common cancers in addition to operable liver cancer.
Please educate yourself dude! Don't try to sabotage this story for others.....But more importantly for you: save some face! 1) get your facts correct; and 2) at least be consistent!!
Nong!
Tharlow,You are totally inconsistent. In a ChemGenex (CXS) post,...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.30M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| PGL (ASX) Chart |
Day chart unavailable